|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||58.37 - 60.36|
|52-week range||58.37 - 60.36|
|Beta (5Y monthly)||1.78|
|PE ratio (TTM)||N/A|
|Earnings date||08 May 2023 - 12 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The Yahoo Finance Live team discusses the sharp drop in Novavax stock on Wednesday.
Novavax warns of uncertain 2023 outlook as COVID-19 market turns commercial and new CEO calls for pipeline assessment.
Yahoo Finance’s Anjalee Khemlani joins the Live show to discuss the decline in stock for Novavax following quarterly earnings, as well as news that Eli Lilly will reduce the cost of its insulin price by 70%.